NCT00152100View on ClinicalTrials.gov

Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Severe Combined Immunodeficiency
Interventions
PROCEDURE

Stem cell transplant

DRUG

Filgrastim, Alemtuzumab

DEVICE

Miltenyi CliniMACS

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00152100 - Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome | Biotech Hunter | Biotech Hunter